4DMedical is trading at A$4.22, up 5.76%, with no clear company-specific catalyst identified.
- The latest listed ASX filing was a September 27 notice that a substantial holder ceased to hold. It was marked not price-sensitive, and no direct link to the share rise was reported.
- The broader market context was weak; available sources did not establish the session’s volume or a specific cause.